Cargando…

Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment

BACKGROUND: The interaction between cancer cells and stromal cells has a significant contribution in tumorigenesis and tumor development, and plays an anti-tumor immune effect under the regulation of drug resistance-related genes, which affects the outcome of patients. Coiled-coil domain-containing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Liang, Chen, Peixin, Wang, Hao, Zhao, Lishu, Guo, Haoyue, Jiang, Minlin, Zhao, Sha, Li, Wei, Zhu, Jun, Yu, Jia, Dai, Jiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904958/ https://www.ncbi.nlm.nih.gov/pubmed/35281414 http://dx.doi.org/10.21037/tcr-21-1841

Ejemplares similares

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
por: Chen, Peixin, et al.
Publicado: (2021)

Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Guo, Haoyue, et al.
Publicado: (2021)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2021)

Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research
por: Wang, Hao, et al.
Publicado: (2021)

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
por: He, Jiarong, et al.
Publicado: (2022)

The application of artificial intelligence in lung cancer: a narrative review
por: Zhang, Huixian, et al.
Publicado: (2021)

The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2023)

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2023)

A narrative review of tumor heterogeneity and challenges to tumor drug therapy
por: Zhu, Liang, et al.
Publicado: (2021)

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2021)

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
por: Zhu, Kaibo, et al.
Publicado: (2021)

The Lung Adenocarcinoma Microenvironment Mining and Its Prognostic Merit
por: Zhao, Rongchang, et al.
Publicado: (2020)

Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma
por: Zhu, Xinying, et al.
Publicado: (2020)

Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
por: Guo, Haoyue, et al.
Publicado: (2020)

Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2020)

Wnt signaling pathway-derived score for predicting therapeutic resistance and tumor microenvironment in lung adenocarcinoma
por: Zhou, Hao-min, et al.
Publicado: (2023)

Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma
por: Zhao, Chen, et al.
Publicado: (2023)

Cellular components in tumor microenvironment of neuroblastoma and the prognostic value
por: Zhong, Xiaodan, et al.
Publicado: (2019)

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
por: Wang, Kun, et al.
Publicado: (2022)

Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas
por: Zhao, Xin, et al.
Publicado: (2020)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2023)

Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma
por: Yuan, Jingyan, et al.
Publicado: (2020)

Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review
por: Cai, Yiyi, et al.
Publicado: (2021)

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure
por: Chen, Peixin, et al.
Publicado: (2020)

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database
por: Yang, Hao, et al.
Publicado: (2020)

Mining TCGA database for genes of prognostic value in glioblastoma microenvironment
por: Jia, Di, et al.
Publicado: (2018)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

Investigation of Diagnostic and Prognostic Value of CLEC4M of Non-Small Cell Lung Carcinoma Associated with Immune Microenvironment
por: Liu, Huan, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis
por: Liu, Yi, et al.
Publicado: (2021)

Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer
por: Chen, Dongfang, et al.
Publicado: (2022)

Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma
por: Shi, Yuan-Xiang, et al.
Publicado: (2016)

mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer
por: Chen, Peixin, et al.
Publicado: (2021)

Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer
por: Tang, Zhuoran, et al.
Publicado: (2022)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
por: Xu, Zhan-yu, et al.
Publicado: (2020)

Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
por: Sun, Hao-Ran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_liscvalq5q2bc5udr43clko2t0